ArticleBiotechnology reports (Amsterdam, Netherlands)2019
Recovery of laccase-producing gammaproteobacteria from wastewater.
Article in Biotechnology reports (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 53 citations in OpenAlex.
- Article
- Microbial metacommunity dynamics associated with the cyclopoid copepodFrontiers in systems biology · 2026Article
- A high throughput screening process and quick isolation of novel lignin-degrading microbes from large number of natural biomasses.Biotechnology reports (Amsterdam, Netherlands) · 2023Article
- First insights into diversity and potential metabolic pathways of bacterial and fungal communities in the rhizosphere ofBiodiversity data journal · 2023Article
- Four Decades of Laccase Research for Wastewater Treatment: Insights from Bibliometric Analysis.International journal of environmental research and public health · 2022Review
- Advancement of Metatranscriptomics towards Productive Agriculture and Sustainable Environment: A Review.International journal of molecular sciences · 2022Review
- Novel bio-catalytic degradation of endocrine disrupting compounds in wastewater.Frontiers in bioengineering and biotechnology · 2022Article
- Sustainability potentials of novel laccase tinctures fromBiotechnology reports (Amsterdam, Netherlands) · 2020Article
- Production of polyextremotolerant laccase byBiotechnology reports (Amsterdam, Netherlands) · 2019Article
- Aptitude of Oxidative Enzymes for Treatment of Wastewater Pollutants: A Laccase Perspective.Molecules (Basel, Switzerland) · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wastewater environment is a rich source of microorganisms with the capability for the degradation of malicious aromatic pollutants. Although wastewater could be regarded as both a resource and a problem, we intended to elucidate its beneficial aspect in this study sourcing for laccase-producing proteobacteria. Different wastewater samples, from selected wastewater treatment plants (WWTPs), were selectively enriched with some model compounds (vanillin, lignin and potassium hydrogen phthalate) to screen out bacterial isolates that possess excellent degradation potentials. Thereafter, positive isolates were screened for the production of laccase and degradation on phenolic (guaiacol, α-naphthol and syringaldazine) and non-phenolic (ABTS; 2,2 azino-bis -(3-ethylbenzothiazoline 6 sulphonic acid) and PFC; potassium ferrocyanoferrate) substrates characteristic of laccase oxidation. Remarkable laccase producers were identified based on their 16 S rRNA sequences and their secreted enzymes were subjected to substrate specificity test, employing laccase substrates; ABTS, PFC, guaiacol, α-naphthol, 2,6-dimethoxyphenol and pyrogallol. Results showed that wastewater and selective enrichment, in tandem, produced the gammaproteobacteria
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.